Could CAR T-Cells tame MS? new trial launches
Disease control
Not yet recruiting
This early-stage trial tests a new treatment called CABA-201 for people with multiple sclerosis (MS). It uses a patient's own immune cells, modified to target and destroy certain immune cells that may be attacking the nervous system. The study aims to check if this approach is sa…
Phase: PHASE1, PHASE2 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC